Philadelphia, March 10, 2022—Adding the proteasome inhibitor bortezomib to chemotherapy significantly improved overall survival in children and young adults with ...
Bottom Line: For patients with acute lymphoblastic leukemia (ALL) carrying the Philadelphia chromosome and whose disease relapsed after allogeneic hematopoietic ...
Oncotarget published "High expression of Myosin 1g in pediatric acute lymphoblastic leukemia" which reported that class I myosins are molecular motors ...
Oncotarget published "Inhibition of the MAP2K7-JNK pathway with 5Z-7-oxozeaenol induces apoptosis in T-cell acute lymphoblastic leukemia" which reported that mechanistically, 5Z7O-mediated ...
Acute lymphoblastic leukemia (ALL), a cancer involving white blood cells known as lymphocytes, is the most common childhood cancer, representing ...
